Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2i Therapy in Islet Transplantation (SIT)
NCT07228195Phase 4Recruiting
- Sponsor
- University of Minnesota
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in diabetes mellitus (DM), sponsored by University of Minnesota. Started Jul 2026; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07228195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07228195.